New vaccine combo aims to boost immune attack on Hard-to-Treat cancers
Disease control
Terminated
This early-phase trial tests two experimental vaccines (ChAdOx1 and MVA) designed to help the immune system recognize and attack cancer cells. They are given alongside standard chemotherapy and an immune checkpoint inhibitor for people with advanced non-small cell lung cancer or …
Phase: PHASE1, PHASE2 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 17, 2026 04:14 UTC